Investors
News Releases
GreenJay Therapeutics Successfully Completes More than $1 Million in its Seed Round of Financing
Houston, Texas — (June 30, 2023) — GreenJay Therapeutics, Inc. (“GreenJay” or the “Company”), a drug formulation company focused on developing safer, more soluble and more efficacious therapies for patients...
Read More